Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Recent Analysis Shows Eaton Vance, Endocyte, Ion Geophysical, Macerich, SunCoke Energy, and Dolby Laboratories Market Influences — Renewed Outlook, Key Drivers of Growth

MAC, DLB

NEW YORK, Aug. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Eaton Vance Corporation (NYSE:EV), Endocyte, Inc. (NASDAQ:ECYT), Ion Geophysical Corporation (NYSE:IO), Macerich Company (NYSE:MAC), SunCoke Energy, Inc. (NYSE:SXC), and Dolby Laboratories (NYSE:DLB), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EV DOWNLOAD: http://Fundamental-Markets.com/register/?so=EV
ECYT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ECYT
IO DOWNLOAD: http://Fundamental-Markets.com/register/?so=IO
MAC DOWNLOAD: http://Fundamental-Markets.com/register/?so=MAC
SXC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SXC
DLB DOWNLOAD: http://Fundamental-Markets.com/register/?so=DLB

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Eaton Vance Corporation (NYSE:EV), Endocyte, Inc. (NASDAQ:ECYT), Ion Geophysical Corporation (NYSE:IO), Macerich Company (NYSE:MAC), SunCoke Energy, Inc. (NYSE:SXC), and Dolby Laboratories (NYSE:DLB) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 1st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EATON VANCE CORPORATION (EV) REPORT OVERVIEW

Eaton Vance's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Eaton Vance reported revenue of $414.26MM vs $374.63MM (up 10.58%) and basic earnings per share $0.84 vs $0.65 (up 29.23%). For the twelve months ended October 31st, 2017 vs October 31st, 2016, Eaton Vance reported revenue of $1,529.01MM vs $1,342.86MM (up 13.86%) and basic earnings per share $2.54 vs $2.20 (up 15.45%). Eaton Vance is expected to report earnings on August 22nd, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $3.68 and is expected to report on November 20th, 2018.

To read the full Eaton Vance Corporation (EV) report, download it here: http://Fundamental-Markets.com/register/?so=EV

-----------------------------------------

ENDOCYTE, INC. (ECYT) REPORT OVERVIEW

Endocyte's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Endocyte reported revenue of $0.02MM vs $0.01MM (up 27.20%) and basic earnings per share -$0.16 vs -$0.27. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Endocyte reported revenue of $0.07MM vs $0.07MM (unchanged) and basic earnings per share -$1.25 vs -$1.04. Endocyte is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.30. The estimated EPS forecast for the next fiscal year is -$0.77 and is expected to report on February 25th, 2019.

To read the full Endocyte, Inc. (ECYT) report, download it here: http://Fundamental-Markets.com/register/?so=ECYT

-----------------------------------------

ION GEOPHYSICAL CORPORATION (IO) REPORT OVERVIEW

Ion Geophysical's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Ion Geophysical reported revenue of $33.51MM vs $32.56MM (up 2.92%) and basic earnings per share -$1.44 vs -$1.98. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ion Geophysical reported revenue of $197.55MM vs $172.81MM (up 14.32%) and basic earnings per share -$2.55 vs -$5.71. Ion Geophysical is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $1.39 and is expected to report on February 6th, 2019.

To read the full Ion Geophysical Corporation (IO) report, download it here: http://Fundamental-Markets.com/register/?so=IO

-----------------------------------------

MACERICH COMPANY (MAC) REPORT OVERVIEW

Macerich's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Macerich reported revenue of $236.73MM vs $247.05MM (down 4.17%) and basic earnings per share -$0.24 vs $0.48. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Macerich reported revenue of $993.66MM vs $1,041.27MM (down 4.57%) and basic earnings per share $1.02 vs $3.52 (down 71.02%). Macerich is expected to report earnings on October 29th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.96. The estimated EPS forecast for the next fiscal year is $4.13 and is expected to report on February 4th, 2019.

To read the full Macerich Company (MAC) report, download it here: http://Fundamental-Markets.com/register/?so=MAC

-----------------------------------------

SUNCOKE ENERGY, INC. (SXC) REPORT OVERVIEW

SunCoke Energy's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, SunCoke Energy reported revenue of $367.00MM vs $323.20MM (up 13.55%) and basic earnings per share $0.06 vs -$0.38. For the twelve months ended December 31st, 2017 vs December 31st, 2016, SunCoke Energy reported revenue of $1,331.50MM vs $1,223.30MM (up 8.84%) and basic earnings per share $1.90 vs $0.22 (up 763.64%). SunCoke Energy is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $0.36 and is expected to report on January 30th, 2019.

To read the full SunCoke Energy, Inc. (SXC) report, download it here: http://Fundamental-Markets.com/register/?so=SXC

-----------------------------------------

DOLBY LABORATORIES (DLB) REPORT OVERVIEW

Dolby Laboratories' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Dolby Laboratories reported revenue of $301.36MM vs $267.47MM (up 12.67%) and basic earnings per share $0.68 vs $0.50 (up 36.00%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Dolby Laboratories reported revenue of $1,081.45MM vs $1,025.74MM (up 5.43%) and basic earnings per share $1.98 vs $1.85 (up 7.03%). Dolby Laboratories is expected to report earnings on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.35. The estimated EPS forecast for the next fiscal year is $2.64 and is expected to report on October 24th, 2018.

To read the full Dolby Laboratories (DLB) report, download it here: http://Fundamental-Markets.com/register/?so=DLB

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today